Chart calendar Revelation Biosciences, Inc.
Upcoming events on Revelation Biosciences, Inc.
Past events on Revelation Biosciences, Inc.
15/05/2024 17:00 | Annual General Meeting |
10/05/2024 21:52 | Q1 2024 Earnings Release |
22/03/2024 20:15 | Q4 2023 Earnings Release |
18/03/2024 18:00 | Roth Conference |
16/03/2024 | Roth Conference |
13/03/2024 00:30 | Critical Care Nephrology International Conference |
17/01/2024 17:00 | Extraordinary Shareholders Meeting |
13/11/2023 21:05 | Q3 2023 Earnings Release |
12/10/2023 13:45 | Roth Healtcare Opportunities Conference |
11/08/2023 21:10 | Q2 2023 Earnings Release |
07/07/2023 18:00 | Annual General Meeting |
30/03/2023 22:42 | Q4 2022 Earnings Release |
14/03/2023 19:30 | Roth Conference |
19/01/2023 | Extraordinary Shareholders Meeting |
10/11/2022 21:30 | Q3 2022 Earnings Release |
05/10/2022 | Roth Healthcare Opportunities Conference |
15/08/2022 22:30 | Interim 2022 Earnings Release |
16/05/2022 21:01 | Q1 2022 Earnings Release |
07/04/2022 21:30 | Business Update Call |
27/03/2022 | Maxim Group Virtual Growth Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -3,09 -11,7 73.65% | -10,9 -10,9 -0.05% | -8,66 -9,29 6.77% | -9,48 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | -5,08 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EPS USD | Released Forecast Spread | -4 599 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 20/09/21 | 15/04/22 | 30/03/23 | 22/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,59 -2,00 -228.66% | -1,86 -2,12 12.29% | -1,20 -1,89 36.47% | -1,22 -1,21 -0.52% | -1,62 -1,64 0.99% | -1,93 -1,72 -12.64% | -2,78 -2,11 -31.46% | -2,33 -2,95 21.26% | -1,90 -2,55 25.44% | -2,07 | -2,60 | -2,50 | ||
Announcement Date | 16/05/22 | 15/08/22 | 10/11/22 | 30/03/23 | 22/05/23 | 11/08/23 | 09/11/23 | 22/03/24 | 10/05/24 | - | - | - | - | - |
15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Revelation Biosciences, Inc.
07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |